Pricing Log in Create free account

IN8bio, Inc. (INAB) vs Intensity Therapeutics Inc. (INTS)

IN8bio, Inc. and Intensity Therapeutics Inc. are both Biotechnology companies. IN8bio, Inc. and Intensity Therapeutics Inc. are of similar size ($11.7M and $11.0M). Across the 10 metrics below, IN8bio, Inc. leads on 6 and Intensity Therapeutics Inc. on 4.

Valuation

Metric INAB INTS Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.18 0.98 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.03 0.64
EV/Sales n/m n/m 9.21
Earnings yield (145.95%) (50.85%) (33.15%)
Free cash flow yield (67.71%) (98.74%) (25.50%)

Profitability

Metric INAB INTS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (111.11%) (195.88%) (56.36%)
Return on assets (90.80%) (139.85%) (48.04%)
Return on invested capital (2,948.56%) 0.00% 0.00%

Growth

Metric INAB INTS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 74.06% 70.74% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INAB INTS Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 8.21 5.00 4.72
Net debt to EBITDA 1.56 0.99 0.96

Dividend

Metric INAB INTS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INAB INTS Biotechnology median
Market cap 11.68m 11.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack